These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39265074)

  • 1. A Magnetically Driven Biodegradable Microsphere with Mass Production Capability for Subunit Vaccine Delivery and Enhanced Immunotherapy.
    Zhang Q; Qu Y; Zhao H; Chen S; Liu Z; Li J; Li Y; Li J; Sun D
    ACS Appl Mater Interfaces; 2024 Sep; 16(38):50344-50359. PubMed ID: 39265074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.
    Zha Y; Fu L; Liu Z; Lin J; Huang L
    J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides.
    Goto K; Ueno T; Sakaue S
    J Biosci Bioeng; 2024 Sep; 138(3):254-260. PubMed ID: 38890051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.
    Wang K; Yang Y; Xue W; Liu Z
    Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy.
    Liu J; Cui Y; Cabral H; Tong A; Yue Q; Zhao L; Sun X; Mi P
    ACS Nano; 2024 Sep; 18(37):25826-25840. PubMed ID: 39196858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A supramolecular protein chaperone for vaccine delivery.
    Wang Z; Shang Y; Tan Z; Li X; Li G; Ren C; Wang F; Yang Z; Liu J
    Theranostics; 2020; 10(2):657-670. PubMed ID: 31903143
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.
    Villegas-Mendez A; Garin MI; Pineda-Molina E; Veratti E; Bueren JA; Fender P; Lenormand JL
    Mol Ther; 2010 May; 18(5):1046-53. PubMed ID: 20179681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
    Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
    Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
    Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy.
    Wang C; Tang H; Duan Y; Zhang Q; Shan W; Wang X; Ren L
    J Colloid Interface Sci; 2024 Nov; 674():92-107. PubMed ID: 38917715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
    Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
    J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable Microrobots for DNA Vaccine Delivery.
    Chen S; Tan Z; Liao P; Li Y; Qu Y; Zhang Q; Yang M; Chan KWY; Zhang L; Man K; Chen Z; Sun D
    Adv Healthc Mater; 2023 Aug; 12(21):e2202921. PubMed ID: 37156574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-Functionalized Biodegradable Nanoparticles Efficiently Deliver DNA Vaccine and Promote Anti-tumor Immunity.
    Sun B; Zhao X; Wu Y; Cao P; Movahedi F; Liu J; Wang J; Xu ZP; Gu W
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):14015-14027. PubMed ID: 33751882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
    Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
    J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses.
    Kumar S; Kesharwani SS; Kuppast B; Bakkari MA; Tummala H
    J Control Release; 2017 Sep; 261():263-274. PubMed ID: 28669593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses.
    Mattheolabakis G; Lagoumintzis G; Panagi Z; Papadimitriou E; Partidos CD; Avgoustakis K
    Int J Pharm; 2010 Jan; 385(1-2):187-93. PubMed ID: 19874877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.